Abstract: This invention provides a device for implantation directly into the spinal cord for the purpose of treating back pain. Electrodes on a backing that conforms directly to the spinal cord are installed as a source of electrical stimulation and pain relief. The floating electrodes can be flexibly mounted to the substrate such that when the electrode array is implanted into the subject, individual electrodes float or move resiliently relative to the substrate to an extent sufficient to accommodate pulsations of the surface of the spinal cord within the dura.

Abstract: Automated detection of pipeline ruptures using machine learning techniques. A plurality of independent rupture detection techniques each generate a status determination indicative of whether the pipeline is ruptured. A combiner utilizing a neural network algorithm analyzes the status determinations to generate a single, high-confidence status determination indicative of whether the pipeline is ruptured.

Abstract: A compound of formula (I) or a salt thereof: wherein R1 represents a five-membered aromatic heterocycle selected from a N- or a C-linked mono- or di-substituted pyrazole, an N- or a C-linked optionally mono- or di-substituted triazole or an N- or a C-linked optionally mono- or di-substituted imidazole, which five-membered aromatic heterocycle may be substituted by one or two of the groups selected a methyl group, an ethyl group, a fluorine atom, a hydroxymethyl group, a 2-hydroxypropan-2-yl group, a trifluoromethyl group, a difluoromethyl group or a fluoromethyl group, except that when R1 represents an N-linked mono- or di-substituted pyrazole, R1 does not represent 3,5-Dimethyl-1H-pyrazol-1-yl, 5-Methyl-1H-pyrazol-1-yl, 5-Ethyl-3-methyl-1H-pyrazol-1-yl, 3,5-Diethyl-1H-pyrazol-1-yl, 4-Fluoro-3,5-dimethyl-1H-pyrazol-1-yl, 3-Methyl-1H-pyrazol-1-yl or 1H-pyrazol-1-yl.

Abstract: A cranial plate is provided for use after a craniectomy. The plate is mounted to the skull and protects the brain exposed in the skull opening. A plate is initially spaced above the skull with gaskets or spacers so as to preclude pressure on the brain. The gaskets or spacers are resorptive, or otherwise dissolve or shrink over time, until the plate settles upon the skull. An elastic web extending over the plate provides a constant force to pull the plate towards the skull as the spacers shrink. The plate is secured to the skull using screws. The plate may include alignment posts residing adjacent the skull opening to maintain proper positioning of the plate as the spacers shrink. The plate eliminates the need for a second cranioplasty surgical procedure.

Abstract: A compound of formula (I): being 4-(3-Fluoro-3-(2-(5, 6, 7, 8-tetrahydro-1, 8-naphthyridin-2-yl) ethyl) pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy) phenyl) butanoic acid, or a salt thereof.

Abstract: This invention provides a device for implantation directly into the spinal cord for the purpose of treating back pain. Electrodes on a backing that conforms directly to the spinal cord are installed as a source of electrical stimulation and pain relief. The floating electrodes can be flexibly mounted to the substrate such that when the electrode array is implanted into the subject, individual electrodes float or move resiliently relative to the substrate to an extent sufficient to accommodate pulsations of the surface of the spinal cord within the dura.

Abstract: Packages for containing consumer goods are disclosed. The consumer goods may be disposable, durable or semi-durable. Absorbent article is one class of disposable articles that may be contained by packages. The packages comprise an opening that is covered by an overlabel. The overlabel is at least partially peeled off of the package so that articles contained within the package can be removed through the now exposed opening. In some embodiments, the package can be reclosed by covering the opening with the overlabel. A consumer may wish to dispose of a used article by placing the article back into the package via the opening and re-adhering the overlabel.

Abstract: A compound according to formula (I) wherein R1 is hydrogen, cyclopropyl, or pyrazolyl, wherein said pyrazolyl is optionally substituted by one or two methyl groups; or a pharmaceutically acceptable salt thereof.

Abstract: A compound of formula (I): wherein R is H or F; or a salt thereof.

Abstract: A method for altering the appearance of molded articles is described herein. The method includes the steps of providing a plurality of articles; feeding a first article to a conveyor; transporting the first article to a treatment station; activating an activatable colorant of the first article by exposing the first article to at least one energy source, thereby causing a color change in the first article; manipulating the exposure of the first article to create a first discernable pattern in the first article; feeding a second article to the conveyor; transporting the second article to the treatment station; activating an activatable colorant of the second article by exposing the second article to the at least one energy source, thereby causing a color change in the second article; and manipulating the exposure of the second article to create a second discernable pattern in the second article.

Abstract: A compound of formula (I): which is 4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl)butanoic acid, or a salt thereof.

Abstract: This invention provides a new technology for management of back pain by stimulating the spinal cord in a manner that renders it refractory to transmission of deleterious or undesirable sensory input. The electrical stimulus comprises high frequency pulses in a regular or complex pattern or that are stochastically produced under microprocessor control. The stimulus is applied directly to the surface of the spinal cord from within the spinal canal, which provides important benefits over previous technology. The stimulus alleviates symptoms and signs of back pain, while minimizing the risk of side effects such as paresthesia, and potentially minimizing the effects on motor neuron transmission and proprioception.

Abstract: A switching module is adapted to configure switches between source buffers and rendering pipelines. Each of the switches has one or more selection inputs each representing encoded data for a media track from one of the source buffers. Each of the switches also has a selection output associated with one of the rendering pipelines for decoding and rendering. The switching module is further adapted to use the switches to manage which of the media tracks, if any, have encoded data routed to the rendering pipelines during media streaming. The rendering pipelines can include a video rendering pipeline and one or more audio rendering pipelines, where the switching module is part of a media engine adapted to determine a clock source in one of the audio rendering pipeline(s), and the clock source is used to drive synchronization of the media tracks.

Abstract: A compound of formula (I): wherein R is H or F; or a salt thereof.

Abstract: A compound of formula (I): which is 4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl)butanoic acid, or a salt thereof.

Abstract: A compound according to formula (I) wherein R1 is hydrogen, cyclopropyl, or pyrazolyl, wherein said pyrazolyl is optionally substituted by one or two methyl groups; or a pharmaceutically acceptable salt thereof.

Abstract: A compound of formula (I) or a salt thereof: wherein R1 represents a five-membered aromatic heterocycle selected from a N- or a C-linked mono- or di-substituted pyrazole, an N- or a C-linked optionally mono- or di-substituted triazole or an N- or a C-linked optionally mono- or di-substituted imidazole, which five-membered aromatic heterocycle may be substituted by one or two of the groups selected a methyl group, an ethyl group, a fluorine atom, a hydroxymethyl group, a 2-hydroxypropan-2-yl group, a trifluoromethyl group, a difluoromethyl group or a fluoromethyl group, except that when R1 represents an N-linked mono- or di-substituted pyrazole, Ri does not represent 3,5-Dimethyl-1H-pyrazol-1-yl, 5-Methyl-1H-pyrazol-1-yl, 5-Ethyl-3-methyl-1H-pyrazol-1-yl, 3,5-Diethyl-1H-pyrazol-1-yl, 4-Fluoro-3,5-dimethyl-1H-pyrazol-1-yl, 3-Methyl-1H-pyrazol-1-yl or 1H-pyrazol-1-yl.

Abstract: A cranial plate is provided for use after a craniectomy. The plate is mounted to the skull and protects the brain exposed in the skull opening. A plate is initially spaced above the skull with gaskets or spacers so as to preclude pressure on the brain. The gaskets or spacers are resorptive, or otherwise dissolve or shrink over time, until the plate settles upon the skull. An elastic web extending over the plate provides a constant force to pull the plate towards the skull as the spacers shrink. The plate is secured to the skull using screws. The plate may include alignment posts residing adjacent the skull opening to maintain proper positioning of the plate as the spacers shrink. The plate eliminates the need for a second cranioplasty surgical procedure.

Abstract: Management of the health status of an animal colony using a plurality of blood collection cards and the analysis of dried blood from members of the colony that has been collected on the cards. Members of the colony may be removed from the colony as a result of the analysis.

Abstract: This invention provides a device for implantation directly into the spinal cord for the purpose of treating back pain. Electrodes on a backing that conforms directly to the spinal cord are installed as a source of electrical stimulation and pain relief. The floating electrodes can be flexibly mounted to the substrate such that when the electrode array is implanted into the subject, individual electrodes float or move resiliently relative to the substrate to an extent sufficient to accommodate pulsations of the surface of the spinal cord within the dura.